Hui Luo
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 16
- Cancer-related molecular mechanisms research 15
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 34
- Cancer Immunotherapy and Biomarkers 30
- Pancreatic and Hepatic Oncology Research 18
- Hepatology top 2%
-
- Gastric Cancer Management and Outcomes 44
- Molecular Biology top 5%
-
- Gastrointestinal Tumor Research and Treatment 15
-
- Immune Cell Function and Interaction 15
- Co-authors
- Rui‐Hua XuMiao‐Zhen QiuDe‐Shen WangYuhong LiDong-sheng ZhangZhao-Lei ZengChao RenXueqiong Zhu
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hui Luo
269 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.7k
- Oncology 2.7k
- Hepatology 340
- Pulmonary and Respiratory Medicine 1.3k
- Molecular Biology 2.4k
Countries citing papers authored by Hui Luo
This map shows the geographic impact of Hui Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Luo more than expected).
Fields of papers citing papers by Hui Luo
This network shows the impact of papers produced by Hui Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Luo. The network helps show where Hui Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 10 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 9 | |
| 15 | 2020 | 33 | |
| 16 | 2019 | 5 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 15 | |
| 19 | 2015 | 5 | |
| 20 | 2013 | 120 |
About Hui Luo
Hui Luo is a scholar working on Oncology, Cancer Research, Gastroenterology, Pulmonary and Respiratory Medicine and Health Informatics, having authored 291 papers that have together received 6.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (44 papers), Colorectal Cancer Treatments and Studies (34 papers), Cancer Immunotherapy and Biomarkers (30 papers), Pancreatic and Hepatic Oncology Research (18 papers), Cancer Genomics and Diagnostics (16 papers), Gastrointestinal Tumor Research and Treatment (15 papers), Immune Cell Function and Interaction (15 papers) and Cancer-related molecular mechanisms research (15 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.7k citations), Hepatology (340 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Molecular Biology (2.4k citations). Hui Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rui‐Hua Xu, Miao‐Zhen Qiu, De‐Shen Wang, Yuhong Li, Dong-sheng Zhang, Zhao-Lei Zeng, Chao Ren, Xueqiong Zhu, Feng Wang and Feng-Hua Wang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Tumor Biology, Journal of Translational Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.